CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
706-720 of 1026
Insights From Global Key Opinion Leaders on Optimizing Patient Care in Gynecologic Malignances
MinuteCE®Insights From Global Key Opinion Leaders on Optimizing Patient Care in Gynecologic Malignances
Susana Campos, MD, MPH
Nicoletta Colombo, MD
Incorporation of guideline-concordant care for first-line treatment of a patient with metastatic urothelial carcinoma
MinuteCE®Incorporation of guideline-concordant care for first-line treatment of a patient with metastatic urothelial carcinoma
Ignacio Duran, MD
Sandy Srinivas, MD
First-Line Maintenance Therapy Using PARP Inhibitors for Ovarian Cancer
MinuteCE®First-Line Maintenance Therapy Using PARP Inhibitors for Ovarian Cancer
Nicoletta Colombo, MD
Ritu Salani, MD, MBA
Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH
CME/CE Broadcast ReplayPulmonary Hypertension: Comorbidities With PAH and Group 2 PH
Vallerie V. McLaughlin, MD
Thomas Cascino, MD
Bradley A. Maron, MD
Pulmonary Hypertension Management: Practice Trends and Updates
CME/CE Broadcast ReplayPulmonary Hypertension Management: Practice Trends and Updates
Vallerie V. McLaughlin, MD
Victor Moles, MD
Ioana Preston, MD
Implementing Guideline-Concordant Care Into a Targeted Therapy Approach for Patients With Platinum-Resistant Ovarian Cancer
MinuteCE®Implementing Guideline-Concordant Care Into a Targeted Therapy Approach for Patients With Platinum-Resistant Ovarian Cancer
Susana Campos, MD, MPH
Ritu Salani, MD, MBA
- advertisement
Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer
MinuteCE®Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer
Susana Campos, MD, MPH
Ritu Salani, MD, MBA
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
CME/CEAdvances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Naim Alkhouri, MD, FAASLD, DABOM
Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment
MinuteCE®Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment
Nicholas J. Silvestri, MD
Jeffrey Allen, MD
Autoantibodies in CIDP: Prevalence and Diagnostic Implications
MinuteCE®Autoantibodies in CIDP: Prevalence and Diagnostic Implications
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
MinuteCE®Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Expert Peer Discussion: Integrating Novel HER3-Directed ADCs Upon Disease Progression Following EGFR TKI and Platinum Chemotherapy
MinuteCE®Expert Peer Discussion: Integrating Novel HER3-Directed ADCs Upon Disease Progression Following EGFR TKI and Platinum Chemotherapy
Pasi Antero Jänne, MD, PhD
Helena Yu, MD
- advertisement
Overcoming EGFR Resistance With HER3-Directed ADCs
MinuteCE®Overcoming EGFR Resistance With HER3-Directed ADCs
Helena Yu, MD
Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs
MinuteCE®Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs
Helena Yu, MD
Pasi Antero Jänne, MD, PhD
Case Application: Patients With EGFRm Resistance Post TKI and Platinum Chemotherapy
MinuteCE®Case Application: Patients With EGFRm Resistance Post TKI and Platinum Chemotherapy
Pasi Antero Jänne, MD, PhD
Helena Yu, MD
